Status:
COMPLETED
Comparison of Acute Tart Cherry Supplement Formulation and Dose on Inflammation and Oxidative Capacity
Lead Sponsor:
Ohio University
Collaborating Sponsors:
Marywood University
Conditions:
Inflammation
Oxidative Stress
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
A comparison of acute tart cherry formations (juice vs. powdered) and doses (single vs. twice daily) on inflammation and oxidative capacity.
Detailed Description
Participants will be randomly allocated to a group: one tart cherry capsule daily, two tart cherry capsules daily, one 8oz. bottle of tart cherry juice daily, two 8oz. bottles of tart cherry juice tak...
Eligibility Criteria
Inclusion
- free of cardiovascular, metabolic and inflammatory conditions
- non-smokers
- no known allergy to cherries or cherry juice
- not be taking food supplements (turmeric/curcumin, cherry products, greens, etc.).
Exclusion
- quit smoking less than one year ago.
- currently being treated for arthritis or an inflammatory condition.
- currently being treated for uncontrolled cardiovascular disease, high blood pressure, diabetes, fibromyalgia, or irritable bowel syndrome.
- pregnant.
- regularly consume cherries or are allergic to cherries or dairy.
- currently use anti-inflammatory medications,
- have used corticosteroids in the last two months.
Key Trial Info
Start Date :
September 15 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2017
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT04497077
Start Date
September 15 2015
End Date
May 30 2017
Last Update
August 4 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.